Precise Biometrics announces outcome in the i...

This is a technical warrant update, not a signal of business growth or value creation.

What the company is saying

Precise Biometrics AB is informing investors about the outcome of a substitute warrant issuance tied to its merger with Fingerprint Cards AB. The company’s core narrative is strictly procedural: it details the mechanics of issuing 1,855,541,003 Substitute Warrants to holders of Fingerprint Cards’ 2025:1 (TO8) warrants. The announcement emphasizes that these Substitute Warrants are issued free of charge, with a nominal total cash consideration of approximately SEK 62,800 to be paid to warrant holders. It highlights the entitlement ratio—222 Substitute Warrants grant the right to subscribe for one new ordinary share in Precise Biometrics at a price set at 70% of the volume weighted average share price before 11 September 2026, capped at SEK 3.33 per share. The company projects that, if all warrants are exercised, share capital could increase by up to SEK 2,507,487.60 and shares outstanding by 8,358,292. The right to receive these warrants is contingent on holding the relevant Fingerprint Cards warrants as of 15 July 2026 or the merger registration date. The announcement is careful to note that settlement and trading of the Substitute Warrants will only begin after the merger is registered with the Swedish Companies Registration Office, and explicitly cautions that there is no certainty the merger will complete as described. The tone is neutral, factual, and avoids any promotional language, with CEO Joakim Nydemark named but not quoted or positioned as a driver of the event. This communication fits a compliance-driven investor relations strategy, focusing on transparency in corporate actions rather than pitching future growth or strategic upside.

What the data suggests

The disclosed numbers are precise but limited in scope, focusing solely on the mechanics of the warrant issuance. The company will issue 1,855,541,003 Substitute Warrants, with a total cash consideration of approximately SEK 62,800—equating to a negligible SEK 0.001008 per warrant. The entitlement ratio is 222:1, meaning a holder needs 222 Substitute Warrants to subscribe for a single new share. The subscription price is set at 70% of the volume weighted average share price over the ten trading days before 11 September 2026, but cannot exceed SEK 3.33 per share. If every warrant is exercised, the maximum increase in share capital is SEK 2,507,487.60 and the number of shares rises by 8,358,292. There is no information on revenue, profit, cash flow, or operational performance, and no period-over-period data is provided. The gap between what is claimed and what is evidenced is minimal, as the announcement makes no claims about business impact or value creation. The financial disclosures are complete for the warrant process but wholly insufficient for assessing the company’s broader financial health or trajectory. An independent analyst would conclude that this is a technical update with no immediate implications for profitability, growth, or shareholder value.

Analysis

The announcement is a factual update on the mechanics of substitute warrant issuance related to a merger, with all key figures (number of warrants, cash consideration, entitlement ratio, and potential share capital increase) clearly disclosed. There is no promotional or exaggerated language, and the tone remains strictly procedural. While some claims are forward-looking (e.g., settlement and trading admission contingent on merger registration), these are standard for such corporate actions and are not presented as aspirational or as evidence of future business success. No operational, revenue, or profitability data is disclosed, and there are no claims about business growth or financial impact. The announcement does not attempt to frame the warrant issuance as a value-creating event, nor does it overstate the significance of the action. The gap between narrative and evidence is minimal, as the language is proportionate to the disclosed facts.

Risk flags

• ●Operational risk: The entire process is contingent on the successful registration of the merger with the Swedish Companies Registration Office. If the merger is delayed or fails, the issuance and settlement of Substitute Warrants may not occur, directly impacting warrant holders and undermining the announced structure.
• ●Execution risk: The company explicitly states there is no certainty the merger will be completed as described or at all. This introduces significant uncertainty for investors relying on the timeline or mechanics of the warrant issuance.
• ●Disclosure risk: The announcement provides no information on the company’s operational performance, revenue, profitability, or cash flow. Investors are left without context for how this corporate action fits into the company’s financial health or strategy.
• ●Financial impact risk: The cash consideration per warrant is negligible (SEK 0.001008), and the maximum potential capital raised from full warrant exercise is not quantified in terms of proceeds, only in share capital and share count. This makes it difficult to assess the true financial impact of the action.
• ●Forward-looking risk: A majority of the claims are forward-looking, including the settlement, trading admission, and potential share capital increase. All are dependent on future events that may not materialize as planned.
• ●Dilution risk: If all Substitute Warrants are exercised, the number of shares outstanding will increase by 8,358,292, potentially diluting existing shareholders. The announcement does not discuss how this dilution might affect share value or control.
• ●Market risk: The subscription price for new shares is tied to the market price in September 2026, introducing uncertainty about the attractiveness of exercising the warrants and the potential for capital raised.
• ●Geographic and regulatory risk: The process is subject to Swedish regulatory approval and market conditions, which may introduce additional delays or complications not addressed in the announcement.

Bottom line

For investors, this announcement is a procedural update on a substitute warrant issuance linked to a pending merger, not a signal of operational progress or financial improvement. The company’s narrative is credible in that it sticks to the facts and avoids hype, but it offers no insight into business fundamentals, growth prospects, or profitability. CEO Joakim Nydemark is named as a matter of record, but his involvement does not imply any additional strategic significance or institutional endorsement. To change this assessment, the company would need to disclose how the merger and warrant issuance will affect revenue, profit, or strategic positioning, and provide concrete financial targets or operational milestones. Key metrics to watch in future reporting include actual merger completion, the number of warrants exercised, proceeds raised from share subscriptions, and any subsequent impact on earnings per share or business performance. From an investment perspective, this announcement is not actionable—it is a compliance-driven disclosure with no immediate or medium-term implications for shareholder value. The most important takeaway is that this is a technical step in a merger process, not a catalyst for investment or a sign of underlying business momentum.

Announcement summary

(LSE/AIM:0JDU) Precise Biometrics AB announced the outcome in the issuance of substitute warrants to holders of warrants of series 2025:1 (TO8) in Fingerprint Cards AB, with 1,855,541,003 Substitute Warrants to be issued and approximately SEK 62,800 to be paid to the Warrant Holders. The Substitute Warrants are issued free of charge and settlement of the cash consideration and delivery of the Substitute Warrants will start in connection with final registration of the merger with the Swedish Companies Registration Office. Two hundred and twenty-two (222) Substitute Warrants entitle the holder to subscribe for one (1) new ordinary share in Precise Biometrics at a subscription price equal to 70 percent of the volume weighted average share price of Precise Biometrics’ share on Nasdaq Stockholm during the ten trading days preceding, but not including, 11 September 2026, however never exceeding SEK 3.33 per share. Provided full exercise of the Substitute Warrants, the share capital of Precise Biometrics will increase by a maximum of SEK 2,507,487.60 and the number of shares will increase by 8,358,292. The right to receive Substitute Warrants is granted to the Warrant Holders who, as of 15 July 2026, or such other date on which the merger is finally registered, are holders of warrants of series 2025:1 (TO8) in Fingerprint Cards. The Substitute Warrants will be admitted to trading on Nasdaq Stockholm in connection with the final registration of the merger. The company projects that the merger will be completed in the manner and timeframe described, but notes there can be no certainty.

Disagree with this article?